Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aiming towards hepatitis C virus elimination in Greece.
Papatheodoridis GV, Goulis J, Sypsa V, Lionis C, Manolakopoulos S, Elefsiniotis I, Anagnostou O, Tsoulas C, Hatzakis A, Dalekos GN. Papatheodoridis GV, et al. Among authors: anagnostou o. Ann Gastroenterol. 2019 Jul-Aug;32(4):321-329. doi: 10.20524/aog.2019.0375. Epub 2019 Apr 5. Ann Gastroenterol. 2019. PMID: 31263353 Free PMC article.
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys.
Touloumi G, Karakosta A, Sypsa V, Petraki I, Anagnostou O, Terzidis A, Voudouri NM; Doctors Of The World Greek Delegation; Gavana M, Vantarakis A, Rachiotis G, Kantzanou M, Rosenberg T, Papatheodoridis G, Hatzakis A; Hprolipsis Study Group. Touloumi G, et al. Among authors: anagnostou o. JMIR Res Protoc. 2020 Jan 31;9(1):e13578. doi: 10.2196/13578. JMIR Res Protoc. 2020. PMID: 32004142 Free PMC article.
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin.
Striki A, Manolakopoulos S, Deutsch M, Mela M, Kalafateli M, Schini M, Anagnostou O, Triantos C, Andreadis I, Ketikoglou I, Papatheodoridis G, Pectasides D. Striki A, et al. Among authors: anagnostou o. J Viral Hepat. 2014;21(9):624-32. doi: 10.1111/jvh.12197. Epub 2013 Nov 13. J Viral Hepat. 2014. PMID: 24224747
Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
Manolakopoulos S, Deutsch MJ, Anagnostou O, Karatapanis S, Tiniakou E, Papatheodoridis GV, Georgiou E, Manesis E, Tzourmakliotis D, Archimandritis AJ. Manolakopoulos S, et al. Among authors: anagnostou o. Liver Int. 2010 Nov;30(10):1454-60. doi: 10.1111/j.1478-3231.2010.02341.x. Epub 2010 Sep 16. Liver Int. 2010. PMID: 20846344
Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis.
Kranidioti H, Chatzievagelinou C, Protopapas A, Papatheodoridi M, Zisimopoulos K, Evangelidou E, Antonakaki P, Vlachogiannakos J, Triantos C, Elefsiniotis I, Goulis J, Mela M, Anagnostou O, Tsoulas C, Deutsch M, Papatheodoridis G, Manolakopoulos S. Kranidioti H, et al. Among authors: anagnostou o. Ann Gastroenterol. 2018 Sep-Oct;31(5):598-603. doi: 10.20524/aog.2018.0293. Epub 2018 Jul 19. Ann Gastroenterol. 2018. PMID: 30174397 Free PMC article.
Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.
Anagnostou O, Manolakopoulos S, Bakoyannis G, Papatheodoridis G, Zisouli A, Raptopoulou-Gigi M, Manesis E, Ketikoglou I, Dalekos G, Gogos C, Vassiliadis T, Tzourmakliotis D, Karatapanis S, Kanatakis S, Zoumpoulis -, Hounta A, Koutsounas S, Giannoulis G, Tassopoulos N, Touloumi G. Anagnostou O, et al. Hippokratia. 2014 Jan;18(1):57-64. Hippokratia. 2014. PMID: 25125954 Free PMC article.
27 results